CN107485584A - A kind of oral care composition - Google Patents
A kind of oral care composition Download PDFInfo
- Publication number
- CN107485584A CN107485584A CN201710635933.1A CN201710635933A CN107485584A CN 107485584 A CN107485584 A CN 107485584A CN 201710635933 A CN201710635933 A CN 201710635933A CN 107485584 A CN107485584 A CN 107485584A
- Authority
- CN
- China
- Prior art keywords
- cordyceps militaris
- oral care
- care composition
- elite
- alcohol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 114
- 241001264174 Cordyceps militaris Species 0.000 claims abstract description 153
- 229930007927 cymene Natural products 0.000 claims abstract description 46
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims abstract description 39
- 229940034610 toothpaste Drugs 0.000 claims abstract description 37
- 239000000606 toothpaste Substances 0.000 claims abstract description 37
- 239000001103 potassium chloride Substances 0.000 claims abstract description 29
- 235000011164 potassium chloride Nutrition 0.000 claims abstract description 29
- 239000002324 mouth wash Substances 0.000 claims abstract description 18
- 229940051866 mouthwash Drugs 0.000 claims abstract description 17
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical group [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 claims description 54
- 235000010333 potassium nitrate Nutrition 0.000 claims description 27
- 239000004323 potassium nitrate Substances 0.000 claims description 27
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 12
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 claims description 12
- 239000011591 potassium Substances 0.000 claims description 12
- 229960003975 potassium Drugs 0.000 claims description 12
- 229910052700 potassium Inorganic materials 0.000 claims description 12
- 229910001414 potassium ion Inorganic materials 0.000 claims description 12
- 241000382353 Pupa Species 0.000 claims description 10
- IRXRGVFLQOSHOH-UHFFFAOYSA-L dipotassium;oxalate Chemical compound [K+].[K+].[O-]C(=O)C([O-])=O IRXRGVFLQOSHOH-UHFFFAOYSA-L 0.000 claims description 5
- 239000001508 potassium citrate Substances 0.000 claims description 5
- 229960002635 potassium citrate Drugs 0.000 claims description 5
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 claims description 5
- 235000011082 potassium citrates Nutrition 0.000 claims description 5
- 238000005660 chlorination reaction Methods 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 18
- 230000000740 bleeding effect Effects 0.000 abstract description 18
- 208000007565 gingivitis Diseases 0.000 abstract description 14
- 210000000214 mouth Anatomy 0.000 abstract description 10
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 6
- 208000030194 mouth disease Diseases 0.000 abstract description 3
- 238000013329 compounding Methods 0.000 abstract description 2
- 150000002932 p-cymene derivatives Chemical class 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 43
- 238000012360 testing method Methods 0.000 description 31
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 30
- 235000003599 food sweetener Nutrition 0.000 description 21
- 239000003765 sweetening agent Substances 0.000 description 21
- 239000000499 gel Substances 0.000 description 20
- 239000000463 material Substances 0.000 description 18
- 235000013599 spices Nutrition 0.000 description 17
- 239000002562 thickening agent Substances 0.000 description 16
- 238000002360 preparation method Methods 0.000 description 15
- 239000000377 silicon dioxide Substances 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 239000003795 chemical substances by application Substances 0.000 description 13
- 230000000694 effects Effects 0.000 description 12
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 12
- 239000004094 surface-active agent Substances 0.000 description 12
- 239000008367 deionised water Substances 0.000 description 11
- 229910021641 deionized water Inorganic materials 0.000 description 11
- 239000002994 raw material Substances 0.000 description 11
- 230000000844 anti-bacterial effect Effects 0.000 description 10
- 239000004088 foaming agent Substances 0.000 description 10
- 235000012239 silicon dioxide Nutrition 0.000 description 10
- 241000894006 Bacteria Species 0.000 description 9
- 230000001580 bacterial effect Effects 0.000 description 9
- 230000001408 fungistatic effect Effects 0.000 description 9
- 239000003002 pH adjusting agent Substances 0.000 description 9
- 239000011734 sodium Substances 0.000 description 9
- 229910052708 sodium Inorganic materials 0.000 description 9
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 8
- KQLDDLUWUFBQHP-UHFFFAOYSA-N Cordycepin Natural products C1=NC=2C(N)=NC=NC=2N1C1OCC(CO)C1O KQLDDLUWUFBQHP-UHFFFAOYSA-N 0.000 description 8
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 8
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 8
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 8
- OFEZSBMBBKLLBJ-BAJZRUMYSA-N cordycepin Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)C[C@H]1O OFEZSBMBBKLLBJ-BAJZRUMYSA-N 0.000 description 8
- OFEZSBMBBKLLBJ-UHFFFAOYSA-N cordycepine Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)CC1O OFEZSBMBBKLLBJ-UHFFFAOYSA-N 0.000 description 8
- 229940041616 menthol Drugs 0.000 description 8
- RCEAADKTGXTDOA-UHFFFAOYSA-N OS(O)(=O)=O.CCCCCCCCCCCC[Na] Chemical compound OS(O)(=O)=O.CCCCCCCCCCCC[Na] RCEAADKTGXTDOA-UHFFFAOYSA-N 0.000 description 7
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical group OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 229940085605 saccharin sodium Drugs 0.000 description 6
- 239000011775 sodium fluoride Substances 0.000 description 6
- 235000013024 sodium fluoride Nutrition 0.000 description 6
- 229910019142 PO4 Inorganic materials 0.000 description 5
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 5
- 239000001768 carboxy methyl cellulose Substances 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 5
- 239000010452 phosphate Substances 0.000 description 5
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 5
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 5
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical group [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 5
- 206010061218 Inflammation Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical group C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 239000004376 Sucralose Substances 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 208000020670 canker sore Diseases 0.000 description 3
- 229960001631 carbomer Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000013355 food flavoring agent Nutrition 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000001683 mentha spicata herb oil Substances 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 229960000502 poloxamer Drugs 0.000 description 3
- 229920001983 poloxamer Polymers 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 235000019721 spearmint oil Nutrition 0.000 description 3
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical group O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 3
- 235000019408 sucralose Nutrition 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 2
- 208000003433 Gingival Pocket Diseases 0.000 description 2
- 241000077903 Monococcus Species 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 241000194019 Streptococcus mutans Species 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- SEGLCEQVOFDUPX-UHFFFAOYSA-N di-(2-ethylhexyl)phosphoric acid Chemical compound CCCCC(CC)COP(O)(=O)OCC(CC)CCCC SEGLCEQVOFDUPX-UHFFFAOYSA-N 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 2
- -1 moisture Substances 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 238000012148 non-surgical treatment Methods 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 230000003239 periodontal effect Effects 0.000 description 2
- 201000001245 periodontitis Diseases 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 235000004237 Crocus Nutrition 0.000 description 1
- 241000596148 Crocus Species 0.000 description 1
- 208000006558 Dental Calculus Diseases 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010018291 Gingival swelling Diseases 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- AQLLBJAXUCIJSR-UHFFFAOYSA-N OC(=O)C[Na] Chemical group OC(=O)C[Na] AQLLBJAXUCIJSR-UHFFFAOYSA-N 0.000 description 1
- 241001248610 Ophiocordyceps sinensis Species 0.000 description 1
- 208000025157 Oral disease Diseases 0.000 description 1
- 201000010183 Papilledema Diseases 0.000 description 1
- 206010033712 Papilloedema Diseases 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-L Phosphate ion(2-) Chemical compound OP([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-L 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000605894 Porphyromonas Species 0.000 description 1
- 241000605862 Porphyromonas gingivalis Species 0.000 description 1
- 206010061926 Purulence Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 206010044029 Tooth deposit Diseases 0.000 description 1
- 208000010641 Tooth disease Diseases 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001775 anti-pathogenic effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 150000003934 aromatic aldehydes Chemical class 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000000022 bacteriostatic agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000004268 dentin Anatomy 0.000 description 1
- 201000002170 dentin sensitivity Diseases 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000004195 gingiva Anatomy 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000002068 microbial inoculum Substances 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 238000011169 microbiological contamination Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000001640 nerve ending Anatomy 0.000 description 1
- 210000002445 nipple Anatomy 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 150000004032 porphyrins Chemical class 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 229960002816 potassium chloride Drugs 0.000 description 1
- 229940093928 potassium nitrate Drugs 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000007910 systemic administration Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000004357 third molar Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000003039 volatile agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Abstract
The invention discloses a kind of oral care composition, includes Cordyceps militaris elite, the alcohol of O cymenes 5 and sylvite.Oral care composition each component compounding use of the present invention, there is high efficiency anti-inflammatory bacteriostasis.The invention also discloses a kind of application of oral care composition in oral care product is prepared；The oral care product is toothpaste, mouthwash or buccal cavity gel, routine use contains the oral care product of the oral cavity composition of the present invention, it can more effectively treat and prevent mouth disease, such as the bleeding of gum redness, gingivitis, hemodia oral problem.
Description
Technical field
The present invention relates to a kind of composition, and in particular to a kind of oral care composition.
Background technology
With the enhancing of consciousness and the raising of quality of the life of the people to health, have greatly to the attention degree of oral care
Enhancing.Most of diseases of people are all by caused by oral cavity, and it is prophylactic important step to keep oral hygiene, if
Tooth is unhygienic, and substantial amounts of microorganism breeds wherein, corrodes tooth, causes halitosis, gum swelling etc., more serious tooth disease
Disease can also result in other serious systemic diseases.
The inflammatory disorderses that gingivitis refers to that gum gum edge and gum nipple are congested, infiltrates, oozes out, are that department of stomatology Emergency call is common
The category such as disease, the toothache of the category traditional Chinese medical science, third molar abscess, bleeding from the gum, gingivitis is one of most common oral diseases of the mankind, all over the world
Each department, each ethnic, each age level, its illness rate are up to more than 90%, and gingivitis turns into prominent oral health problem.
Gingivitis is the inflammation of gingiva tissue, using bleeding gums as principal character, is typically easily gone out when brushing teeth, sucking and chew hard thing
Blood, gum are in scarlet or aubergine, and swelling or soft, surface is shinny, locally there is dental calculus, soft dirt, plaque build-up, advantage gum
Edge is rotten to the corn, and extruding gum edge has a small amount of fester to discharge, and may occur in which that gum papilledema and gingival sulcus are deepened, or even forms gum purulence
It is swollen.The pathogenic factor of most of gingivitis case is caused by local factor, mainly embedding by the bacterial plaque, calculus or food in neck portion
Plug, which stimulates, causes bleeding gums, and oedema produces gingivitis, periodontitis.Gingival sulcus endothelial tissue is congested, and inflammatory reaction makes granulation tissue shape
Into easily causing angiorrhoxis bleeding (such as visit examine method is improper, scaling bleeding) once being upset.The morbidity of some cases
Reason is caused by systemic factor, such as hypertension, coronary heart disease, diabetes, hepatic sclerosis, blood disease.
Clinical treatment gingivitis uses periodental non-surgical treatment more, while coordinates whole body or topical application antibiotic and chemistry
Synthetic drug.Although periodental non-surgical treatment is effective to removing bacterial plaque and controlling inflammation, bacterial plaque is controlled to exist for a long time
Desirable level is highly difficult.Whole body long-term use antibiotic is likely to result in flora imbalance, produces the adverse consequences such as drug resistance,
And medicine local concentration is relatively low.Although periodontal local application can avoid the adverse consequences that systemic administration is likely to occur,
There is in-convenience in use, cause a variety of side effects, produce drug resistance the shortcomings of.In addition, various periodontal local applications agent at present
Most of type predominantly restraining and sterilizing bacteria preparation, or some biological membrane preparations are only capable of playing a part of promoting gingiva tissue regeneration, because
This people expects that one kind both has antiinflammatory and bacteriostatic functions, the oral care substance having no side effect again.
The content of the invention
A kind of oral care composition is provided it is an object of the invention to overcome the shortcomings of the prior art part.
To achieve the above object, the technical scheme taken of the present invention is：A kind of oral care composition, include Cordyceps militaris essence
China, O- cymene -5- alcohol and sylvite；The Cordyceps militaris elite is the mixture of Cordyceps militaris extract and fruiting bodies of cordyceps militaris.
Cordyceps militaris, be the edible mushroom of food and medicament dual-purpose, Cordyceps militaris extract of the present invention, can by commercially available,
It can be the refined extract of fruiting bodies of cordyceps militaris gained after water extract-alcohol precipitation.Fruiting bodies of cordyceps militaris is to pass through Cordyceps militaris spawn
It is inoculated on solid medium, after the regular hour cultivates, the stroma of crocus is differentiated to form from hyphostoma development
(fructification), and this new fresh sporophore is gathered into laggard sector-style again and dry grinded obtained by the processing of powder；Fructification powder passes through water extracting alcohol
After refined processing after heavy, cordycepin, adenosine, cordycepic acid, polysaccharide, SOD enzymes and other functional ingredient are efficiently concentrated, especially
It is cordycepin functional component.
Fruiting bodies of cordyceps militaris in the present invention, it is made up of materials such as moisture, ash content, protein, fat, wherein containing more
Kind volatile compound, it is in the majority with aromatic aldehydes material, there is certain antibacterial and anti-inflammatory effect, but aromatic volatile composition is equal
More than one hour can not be retained under 50 DEG C of extraction temperature.Therefore, the active ingredient in fruiting bodies of cordyceps militaris definitely can not
Remained in above-mentioned refined heating purification process, therefore the present invention is by the addition of fruiting bodies of cordyceps militaris, can allow pupa worm
The grass seed entity volatile ingredient of itself completely enters toothpaste system.
Cordycepin, is first nucleosides separated from fungi antibiotics, molecular structure 3 ,-desoxyadenossine,
There is broad-spectrum antiseptic, research is found, it can suppress the growth of the pathogens such as streptococcus, staphylococcus, and cordycepin
Also there is stronger antiviral activity, therefore be applied to that in oral cavity composition natural antibacterial, anti-inflammatory, antiviral work(can be played
Effect.Because cordycepin is the main antipathogenic composition in Cordyceps militaris elite, and Cordyceps militaris elite addition directly affects cordycepin and existed
Content in oral cavity composition.
The present invention uses fruiting bodies of cordyceps militaris collocation Cordyceps militaris extract, can make in system containing cordycepin, cordyceps sinensis
Outside the multiple efficacies compositions such as acid, polysaccharide, SOD enzymes, the also volatile ingredient containing fruiting bodies of cordyceps militaris itself, so as to allow shield gum
The effect of protecting tooth is played to optimal.
O- cymene -5- alcohol, it is a kind of bactericide of wide spectrum, there is potent infiltration bactericidal action, to golden yellow grape
The oral cavity pathogens such as coccus, porphyromonas gingivalis all have good antibacterial effect, can penetrate into bacterial plaque inner sterilization,
Suitable for inflammatory patients such as gingivitis, periodontitis, optional commercially available prod, such as Nanjing Si Baike biochemistry Industrial Co., Ltd.
Isopropyl Methylphenol etc..
The release of potassium ion, the nerve endings of dentinal tubule can be prevented to be activated, under enough potassium concentrations,
It can avoid pressing Intradental nerve to be upset, the permeability of dentine be reduced, so as to slow down the situation of dentine hypersensitivity.Therefore work as
When in composition containing enough soluble potassium salt and applied in oral care product formulation, help to alleviate tooth to it is cold,
Heat, acid, sweet tea or sensitiveness pain caused by contact.
Cordyceps militaris elite, O- cymene -5- alcohol and sylvite are together applied in oral care composition of the present invention,
Energy compound synergic, while playing hemostasis, shield gum, Shu Min effects, it greatly strengthen the respective anti-inflammatory in oral care respectively
Fungistatic effect.
Preferably, the weight ratio of the Cordyceps militaris elite and the O- cymenes -5- alcohol is：0.5~50:0.1~1；
The ratio between the weight of the O- cymenes -5- alcohol and the amount of material of the Potassium In Potassium ion are：(0.1~1) g：(0.3~1)
mol。
The ratio between the weight of the O- cymenes -5- alcohol and the amount of material of the Potassium In Potassium ion are：(0.1~1) g：
(0.3~1) mol, can also be expressed as：The amount of the weight of the O- cymenes -5- alcohol and the material of the Potassium In Potassium ion
The ratio between be：0.1~1：0.3~1g/mol.
In view of the medicinal effects of composition, when Cordyceps militaris elite, O- cymene -5- alcohol and sylvite use said ratio
When, this effects of antiinflammation and bacteriostasis significantly increases, and can effectively mitigate gum redness bleeding problems.
It is highly preferred that the weight ratio of the Cordyceps militaris elite and the O- cymenes -5- alcohol is：1~30:0.5~
0.8；The ratio between the weight of the O- cymenes -5- alcohol and the amount of material of the Potassium In Potassium ion are：(0.5~0.8) g：
(0.3~0.53) mol.
The ratio between the weight of the O- cymenes -5- alcohol and the amount of material of the Potassium In Potassium ion are：(0.5~0.8)
g：(0.3~0.53) mol, can also be expressed as：The weight of the O- cymenes -5- alcohol and the material of the Potassium In Potassium ion
The ratio between amount be：0.5~0.8：0.3~0.53g/mol.
Cordyceps militaris elite, O- cymene -5- alcohol and sylvite cooperate under aforementioned proportion, anti-inflammatory fungistatic effect more preferably,
Bleeding gums, sensitivity of tooth problem can be efficiently solved.
Preferably, weight percentage of the fruiting bodies of cordyceps militaris in Cordyceps militaris elite is 0.01~20%.
When Cordyceps militaris extract and fruiting bodies of cordyceps militaris use above-mentioned weight ratio, both can give full play to respective effect,
System is set to contain cordycepin, cordycepic acid, polysaccharide, SOD enzymes and a variety of volatile compounds, so as to reach the work(of shield gum shield tooth
Effect.
It is highly preferred that weight percentage of the fruiting bodies of cordyceps militaris in Cordyceps militaris elite is 8~15%.
When Cordyceps militaris extract and fruiting bodies of cordyceps militaris use above-mentioned weight ratio, what the oral care composition reached kills
Bacterium best results.
Preferably, the sylvite is at least one of potassium nitrate, potassium citrate, potassium chloride and potassium oxalate.
Present invention also offers a kind of application of above-mentioned oral care composition in oral care product is prepared；The mouth
Chamber care product is toothpaste, mouthwash or buccal cavity gel.
Preferably, the concentration for the potassium ion that the Potassium In Potassium ion provides in oral care product is 0.3~1mol/
kg。
, can be in oral care product preferably when addition of the potassium ion in oral care product is above-mentioned content
Effects of antiinflammation and bacteriostasis is played, the oral problems such as the bleeding of gum redness, gingivitis, hemodia can be improved.
The beneficial effects of the present invention are：The invention provides a kind of oral care composition, the oral care combination
Thing each component compounding use, there is stronger effects of antiinflammation and bacteriostasis, by oral care composition of the present invention be applied to toothpaste,
In the product of the oral cares such as mouthwash, buccal cavity gel, routine use contains the oral care production of the oral cavity composition of the present invention
Product, it can more effectively treat and prevent mouth disease, such as the bleeding of gum redness, gingivitis, hemodia oral problem.
Embodiment
To better illustrate the object, technical solutions and advantages of the present invention, below in conjunction with specific embodiment to the present invention
It is described further.
Embodiment 1
A kind of toothpaste for including oral care composition of the present invention, the preparation comprising following weight percentage are former
Material：Oral care composition 3.09%, NMF 50%, rubbing agent 22%, thickener 2%, foaming agent 2%, sweetener 1%,
The deionized water of pH adjusting agent 2%, spices 1% and surplus；
Wherein, in the oral care composition, the sylvite is potassium nitrate, the Cordyceps militaris elite, O- cymenes -5-
The weight ratio of alcohol and potassium nitrate is：Cordyceps militaris elite：O- cymene -5- alcohol：Potassium nitrate=0.05:0.01:3.03；The pupa
Lungfit is the mixture of Cordyceps militaris extract and fruiting bodies of cordyceps militaris, the Cordyceps militaris extract and fruiting bodies of cordyceps militaris
Weight ratio is：Cordyceps militaris extract：Fruiting bodies of cordyceps militaris=99.9：0.01；The NMF is D-sorbite；The thickener
For sodium carboxymethylcellulose；The foaming agent is sodium lauroyl sarcosine and the mixture of lauryl sodium sulfate；The friction
The mixture of agent precipitated silica and superfine silicon dioxide, weight of the superfine silicon dioxide in the preparing raw material of the toothpaste
Percentage composition is 2%；The sweetener is saccharin sodium；The spices is menthol；The pH adjusting agent be alkaline phosphate and
Sodium dihydrogen phosphate.
Embodiment 2
A kind of toothpaste for including oral care composition of the present invention, the preparation comprising following weight percentage are former
Material：Oral care composition 15.3%, NMF 50%, rubbing agent 22%, thickener 2%, foaming agent 2%, sweetener 1%,
The deionized water of pH adjusting agent 2%, spices 1% and surplus；
Wherein, in the oral care composition, the sylvite is potassium citrate, the Cordyceps militaris elite, O- cymenes-
The weight ratio of 5- alcohol and potassium citrate is：Cordyceps militaris elite：O- cymene -5- alcohol：Potassium citrate=5:0.1:10.2；It is described
Cordyceps militaris elite is the mixture of Cordyceps militaris extract and fruiting bodies of cordyceps militaris, the Cordyceps militaris extract and fruiting bodies of cordyceps militaris
Weight ratio be：Cordyceps militaris extract：Fruiting bodies of cordyceps militaris=80：20；The NMF is D-sorbite；The thickener is
Sodium carboxymethylcellulose；The foaming agent is sodium lauroyl sarcosine and the mixture of lauryl sodium sulfate；The rubbing agent
The mixture of precipitated silica and superfine silicon dioxide, weight hundred of the superfine silicon dioxide in the preparing raw material of the toothpaste
It is 2% to divide content；The sweetener is saccharin sodium；The spices is menthol；The pH adjusting agent is alkaline phosphate and phosphorus
Acid dihydride sodium.
Embodiment 3
A kind of toothpaste for including oral care composition of the present invention, the preparation comprising following weight percentage are former
Material：Oral care composition 5.18%, NMF 50%, rubbing agent 22%, thickener 2%, foaming agent 2%, sweetener 1%,
The deionized water of pH adjusting agent 2%, spices 1% and surplus；
Wherein, in the oral care composition, the sylvite is potassium nitrate, the Cordyceps militaris elite, O- cymenes -5-
The weight ratio of alcohol and potassium nitrate is：Cordyceps militaris elite：O- cymene -5- alcohol：Potassium nitrate=0.1：0.08：5；The Cordyceps militaris
Elite is the mixture of Cordyceps militaris extract and fruiting bodies of cordyceps militaris, the weight of the Cordyceps militaris extract and fruiting bodies of cordyceps militaris
Than for：Cordyceps militaris extract：Fruiting bodies of cordyceps militaris=92：8；The NMF is D-sorbite；The thickener is carboxymethyl
Sodium cellulosate；The foaming agent is sodium lauroyl sarcosine and the mixture of lauryl sodium sulfate；The rubbing agent precipitation two
The mixture of silica and superfine silicon dioxide, weight percentage of the superfine silicon dioxide in the preparing raw material of the toothpaste
For 2%；The sweetener is saccharin sodium；The spices is menthol；The pH adjusting agent is alkaline phosphate and biphosphate
Sodium.
Embodiment 4
A kind of toothpaste for including oral care composition of the present invention, the preparation comprising following weight percentage are former
Material：Oral care composition 8.4%, NMF 50%, rubbing agent 22%, thickener 2%, foaming agent 2%, sweetener 1%, pH
The deionized water of conditioning agent 2%, spices 1% and surplus；
Wherein, in the oral care composition, the sylvite is potassium nitrate, the Cordyceps militaris elite, O- cymenes -5-
The weight ratio of alcohol and potassium nitrate is：Cordyceps militaris elite：O- cymene -5- alcohol：Potassium nitrate=3：0.05：5.35；The pupa worm
Careless elite is the mixture of Cordyceps militaris extract and fruiting bodies of cordyceps militaris, the weight of the Cordyceps militaris extract and fruiting bodies of cordyceps militaris
Measuring ratio is：Cordyceps militaris extract：Fruiting bodies of cordyceps militaris=85：15；The NMF is D-sorbite；The thickener is carboxylic first
Base sodium cellulosate；The foaming agent is sodium lauroyl sarcosine and the mixture of lauryl sodium sulfate；The rubbing agent precipitation
The mixture of silica and superfine silicon dioxide, weight percent of the superfine silicon dioxide in the preparing raw material of the toothpaste contain
Measure as 2%；The sweetener is saccharin sodium；The spices is menthol；The pH adjusting agent is alkaline phosphate and di(2-ethylhexyl)phosphate
Hydrogen sodium.
Embodiment 5
A kind of toothpaste for including oral care composition of the present invention, the preparation comprising following weight percentage are former
Material：Oral care composition 4.84%, NMF 50%, rubbing agent 22%, thickener 2%, foaming agent 2%, sweetener 1%,
The deionized water of pH adjusting agent 2%, spices 1% and surplus；
Wherein, in the oral care composition, the sylvite is potassium oxalate, the Cordyceps militaris elite, O- cymenes -5-
The weight ratio of alcohol and potassium oxalate is：Cordyceps militaris elite：O- cymene -5- alcohol：Potassium oxalate=2：0.08：2.76；The pupa worm
Careless elite is the mixture of Cordyceps militaris extract and fruiting bodies of cordyceps militaris, the weight of the Cordyceps militaris extract and fruiting bodies of cordyceps militaris
Measuring ratio is：Cordyceps militaris extract：Fruiting bodies of cordyceps militaris=90：10；The NMF is D-sorbite；The thickener is carboxylic first
Base sodium cellulosate；The foaming agent is sodium lauroyl sarcosine and the mixture of lauryl sodium sulfate；The rubbing agent precipitation
The mixture of silica and superfine silicon dioxide, weight percent of the superfine silicon dioxide in the preparing raw material of the toothpaste contain
Measure as 2%；The sweetener is saccharin sodium；The spices is menthol；The pH adjusting agent is alkaline phosphate and di(2-ethylhexyl)phosphate
Hydrogen sodium.
Embodiment 6
A kind of mouthwash for including oral care composition of the present invention, the preparation comprising following weight percentage are former
Material：Oral care composition 5.29%, NMF 16%, food-grade ethanol 4%, surfactant 1.5%, sweetener 0.2%,
Spices 0.5%, sodium fluoride 0.23%, the deionized water of surplus.
Wherein, in the oral care composition, the sylvite is potassium chloride, the Cordyceps militaris elite, O- cymenes -5-
The weight ratio of alcohol and potassium chloride is：Cordyceps militaris elite：O- cymene -5- alcohol：Potassium chloride=3：0.05：2.24；The pupa worm
Careless elite is the mixture of Cordyceps militaris extract and fruiting bodies of cordyceps militaris, the weight of the Cordyceps militaris extract and fruiting bodies of cordyceps militaris
Measuring ratio is：Cordyceps militaris extract：Fruiting bodies of cordyceps militaris=92：8；The NMF is D-sorbite；The surfactant is
The mixture of lauryl sodium sulfate and PEG-60 rilanit specials；The flavouring agent is spearmint oil；The sweetener is sugar
Smart sodium.
Embodiment 7
A kind of mouthwash for including oral care composition of the present invention, the preparation comprising following weight percentage are former
Material：Oral care composition 8.05%, NMF 16%, food-grade ethanol 4%, surfactant 1.5%, sweetener 0.2%,
Spices 0.5%, sodium fluoride 0.23%, the deionized water of surplus.
Wherein, in the oral care composition, the sylvite is potassium chloride, the Cordyceps militaris elite, O- cymenes -5-
The weight ratio of alcohol and potassium chloride is：Cordyceps militaris elite：O- cymene -5- alcohol：Potassium chloride=1：0.05：7；The Cordyceps militaris essence
The mixture of Huawei's Cordyceps militaris extract and fruiting bodies of cordyceps militaris, the weight ratio of the Cordyceps militaris extract and fruiting bodies of cordyceps militaris
For：Cordyceps militaris extract：Fruiting bodies of cordyceps militaris=92：8；The NMF is D-sorbite；The surfactant is 12
The mixture of sodium alkyl sulfate and PEG-60 rilanit specials；The flavouring agent is spearmint oil；The sweetener is saccharin sodium.
Embodiment 8
A kind of mouthwash for including oral care composition of the present invention, the preparation comprising following weight percentage are former
Material：Oral care composition 7%, NMF 16%, food-grade ethanol 4%, surfactant 1.5%, sweetener 0.2%, perfume
Material 0.5%, sodium fluoride 0.23%, the deionized water of surplus.
Wherein, in the oral care composition, the sylvite is potassium chloride, the Cordyceps militaris elite, O- cymenes -5-
The weight ratio of alcohol and potassium chloride is：Cordyceps militaris elite：O- cymene -5- alcohol：Potassium chloride=3：0.05：3.95；The pupa worm
Careless elite is the mixture of Cordyceps militaris extract and fruiting bodies of cordyceps militaris, the weight of the Cordyceps militaris extract and fruiting bodies of cordyceps militaris
Measuring ratio is：Cordyceps militaris extract：Fruiting bodies of cordyceps militaris=92：8；The NMF is D-sorbite；The surfactant is
The mixture of lauryl sodium sulfate and PEG-60 rilanit specials；The flavouring agent is spearmint oil；The sweetener is sugar
Smart sodium.
Embodiment 9
A kind of buccal cavity gel for including oral care composition of the present invention, includes the preparation of following weight percentage
Raw material：Oral care composition 11.05%, thickener 2%, NMF 10%, surfactant 1%, sweetener 0.1%, perfume
Material 0.5%, sodium fluoride 0.23%, the deionized water of surplus.
Wherein, in the oral care composition, the sylvite is potassium nitrate, the Cordyceps militaris elite, O- cymenes -5-
The weight ratio of alcohol and potassium nitrate is：Cordyceps militaris elite：O- cymene -5- alcohol：Potassium nitrate=4：0.05：7；The Cordyceps militaris essence
The mixture of Huawei's Cordyceps militaris extract and fruiting bodies of cordyceps militaris, the weight ratio of the Cordyceps militaris extract and fruiting bodies of cordyceps militaris
For：Cordyceps militaris extract：Fruiting bodies of cordyceps militaris=80：20；The thickener is the mixing of sodium carboxymethylcellulose and carbomer
Thing, the mixture that the surfactant is poloxamer and PEG-60 rilanit specials；The spices is menthol；The sweet tea
Taste agent is Sucralose.
Embodiment 10
A kind of buccal cavity gel for including oral care composition of the present invention, includes the preparation of following weight percentage
Raw material：Oral care composition 9.63%, thickener 2%, NMF 10%, surfactant 1%, sweetener 0.1%, spices
0.5%th, sodium fluoride 0.23%, the deionized water of surplus.
Wherein, in the oral care composition, the sylvite is potassium nitrate, the Cordyceps militaris elite, O- cymenes -5-
The weight ratio of alcohol and potassium nitrate is：Cordyceps militaris elite：O- cymene -5- alcohol：Potassium nitrate=3：0.08：6.55；The pupa worm
Careless elite is the mixture of Cordyceps militaris extract and fruiting bodies of cordyceps militaris, the weight of the Cordyceps militaris extract and fruiting bodies of cordyceps militaris
Measuring ratio is：Cordyceps militaris extract：Fruiting bodies of cordyceps militaris=80：20；The thickener is sodium carboxymethylcellulose and carbomer
Mixture, the mixture that the surfactant is poloxamer and PEG-60 rilanit specials；The spices is menthol；Institute
It is Sucralose to state sweetener.
Embodiment 11
A kind of buccal cavity gel for including oral care composition of the present invention, includes the preparation of following weight percentage
Raw material：Oral care composition 7.4%, thickener 2%, NMF 10%, surfactant 1%, sweetener 0.1%, spices
0.5%th, sodium fluoride 0.23%, the deionized water of surplus.
Wherein, in the oral care composition, the sylvite is potassium nitrate, the Cordyceps militaris elite, O- cymenes -5-
The weight ratio of alcohol and potassium nitrate is：Cordyceps militaris elite：O- cymene -5- alcohol：Potassium nitrate=2：0.05：5.35；The pupa worm
Careless elite is the mixture of Cordyceps militaris extract and fruiting bodies of cordyceps militaris, the weight of the Cordyceps militaris extract and fruiting bodies of cordyceps militaris
Measuring ratio is：Cordyceps militaris extract：Fruiting bodies of cordyceps militaris=80：20；The thickener is sodium carboxymethylcellulose and carbomer
Mixture, the mixture that the surfactant is poloxamer and PEG-60 rilanit specials；The spices is menthol；Institute
It is Sucralose to state sweetener.
Comparative example 1
A kind of comparative example of toothpaste of the present invention, this comparative example the difference is that only with toothpaste described in embodiment 4
The composition of the oral care composition is different, and oral care composition described in this comparative example is O- cymene -5- alcohol and nitric acid
The mixture of potassium, the mass ratio of the O- cymenes -5- alcohol and potassium nitrate are：O- cymene -5- alcohol：Potassium nitrate=0.05:
5.35。
Comparative example 2
A kind of comparative example of toothpaste of the present invention, this comparative example the difference is that only with toothpaste described in embodiment 4
The composition of the oral care composition is different, and oral care composition described in this comparative example is Cordyceps militaris elite and potassium nitrate
The mass ratio of mixture, the Cordyceps militaris elite and potassium nitrate is：Cordyceps militaris elite：Potassium nitrate=3:5.35；The Cordyceps militaris
Elite is the mixture of Cordyceps militaris extract and fruiting bodies of cordyceps militaris, the weight of the Cordyceps militaris extract and fruiting bodies of cordyceps militaris
Than for：Cordyceps militaris extract：Fruiting bodies of cordyceps militaris=85：15.
Comparative example 3
A kind of comparative example of toothpaste of the present invention, this comparative example the difference is that only with toothpaste described in embodiment 4
The composition of oral care composition is different, and oral care composition described in this comparative example is O- cymene -5- alcohol and Cordyceps militaris essence
The mixture of China, the O- cymenes -5- alcohol and the mass ratio of Cordyceps militaris elite are：O- cymene -5- alcohol：Cordyceps militaris elite=
0.05:5.35；The Cordyceps militaris elite is the mixture of Cordyceps militaris extract and fruiting bodies of cordyceps militaris, the Cordyceps militaris extract
Weight ratio with fruiting bodies of cordyceps militaris is：Cordyceps militaris extract：Fruiting bodies of cordyceps militaris=85：15.
Comparative example 4
A kind of comparative example of toothpaste of the present invention, this comparative example the difference is that only with toothpaste described in embodiment 4
This comparative example is free of oral care composition, and other preparing raw materials are same as Example 4.
Comparative example 5
The difference of mouthwash described in a kind of comparative example of mouthwash of the present invention, this comparative example and embodiment 7 is only
It is that this comparative example is free of oral care composition, other preparing raw materials are same as Example 7.
Comparative example 6
A kind of comparative example of buccal cavity gel of the present invention, this comparative example it is different from buccal cavity gel described in embodiment 10 it
Place is only that this comparative example is free of oral care composition, and other preparing raw materials are same as in Example 10.
Embodiment 12
By 1~5 toothpaste of embodiment, 6~8 mouthwash of embodiment, 9~11 buccal cavity gel of embodiment and right
1~3 toothpaste of ratio carries out antibacterial test for common several bacteriums in oral cavity.
Antibacterial method of testing：According to《Disinfection technology standard》2.1.8. anti-(suppression) equal test method, passes through third party's machine
Structure is tested.
The preparation of bacteria inhibition tablet：In the sterilized petri dishes of cleaning, a diameter of 5mm is made, thickness is no more than the suppression of 4mm disks (block)
Microbial inoculum original cream piece, one group of every 4 (blocks).
The preparation of negative control piece：Take sterile dry filter paper piece, every be added dropwise it is standby after sterile distilled water.
The inoculation of test organisms：Concentration is dipped as 5 × 10 with sterile cotton swab5Cfu/ml~5 × 106Cfu/ml test organisms hangs
Liquid, nutrient agar planar surface uniformly smear 3 times, often smear 1 time, flat board should rotate 60 °, finally by cotton swab around
Plate edge is smeared one week, is covered plate, is put drying at room temperature 5min.
Bacteriostatic agent print is placed with：Experiment is placed with 1 microbiological contamination flat board every time, and each flat board is placed with the examination of 4 same test groups
Test print, 1 negative control piece, totally 5.It is placed with aseptic nipper coupongs in planar surface.Between each print center apart
More than 25mm, the periphery with flat board is at a distance of more than 15mm.After being placed with, with the light pressure-like piece of aseptic nipper, it is set to be close to flat board
Surface.Plate is covered, puts 37 DEG C of incubators, culture 16h~18h observation results.With the direct of vernier caliper measurement antibacterial ring size and remember
Record, experiment are repeated 3 times.
The bacterial strain of this test has selected common oral cavity pathogen：Staphylococcus aureus, streptococcus mutans and gum
Porphyrin monococcus.
Antibacterial test evaluation standard：Inhibition zone diameter is more than 7mm person, has been judged to bacteriostasis；Inhibition zone diameter be less than or
Equal to 7mm person, no bacteriostasis is judged to.Test result is shown in Table 1.
1 antibacterial test result of table
As it can be seen from table 1 described in 1~5 toothpaste of embodiment, 6~8 mouthwash of embodiment, embodiment 9~11
The fungistatic effect of staphylococcus aureus, streptococcus mutans and porphyromonas monococcus is superior to buccal cavity gel and comparative example 1
The fungistatic effect of mouthwash described in~4 toothpaste, comparative example 5, buccal cavity gel described in comparative example 6, tooth especially described in comparative example 4
Mouthwash described in cream, comparative example 5, buccal cavity gel described in comparative example 6 can be considered no bacteriostasis, from embodiment 4 and comparative example 1~
The fungistatic effect contrast of 4 toothpaste can show that the fungistatic effect of toothpaste described in embodiment 4 does not add more than comparative example 1~4
Add or only with the addition of Cordyceps militaris elite, the fungistatic effect of the toothpaste of potassium nitrate and O- cymene -5- alcohol two of which, illustrate pupa
Lungfit, potassium nitrate and O- cymene -5- alcohol compound in certain proportion can play a part of Synergistic.
Embodiment 13
Clinical test is carried out to toothpaste of the present invention and 1~4 toothpaste of comparative example, specific testing program is as follows：
First, testing program
Double-blind randomized clinical trial designs, aspirations of the collection 127 with different degrees of gum redness bleeding problems by
Examination person, trial volunteer's age distribution are randomly divided into test group and control group I, II, III, IV at 15~59 years old, by subject, its
The middle people of test group 27, the people of control group I 26, the people of control group II 27, the people of control group III 23, the people of control group IV 24, test group and control
Group I, II, III, IV using 1~4 toothpaste of toothpaste of the present invention and comparative example is used, is adjusted using oral epidemiology respectively
The index of correlation of tooth and gum of the method inspection trial volunteer looked into when using toothpaste 4 weeks and 8 weeks.
2nd, application method
Toothbrush：Soft wire type toothbrush；
Dosage：Test group, the subject of control group I~IV are brushed teeth 2 times sooner or later daily, use 2 grams of toothpaste every time.
3rd, observation item and index
1st, gingival index (GI)
Check gingival margin near, it is remote in, cheek side, the situation in 4 regions of tongue side, be divided into 0~3 grade of standard, 0 point of (gum
Normally)；1 point (not bleeding is examined in gum mild inflammation, color mild change, Mild edema, spy)；2 points of (gum moderate inflammation, colors
Bleeding is examined in red, oedema, light, spy)；3 points (gingivitis is obvious, red and swollen, there is ulcer, automatic hemorrhagic tendency).
2nd, gingival sulcus bleeding index (SBI)
Check gingival margin near, it is remote in, cheek side, the situation in 4 regions of tongue side, be divided into 4 grades, 1 point (not bleeding)；2 points
(bleeding during light spy gingival sulcus, gum outward appearance are normal)；3 points (bleeding when visiting gingival sulcus, gum redden, no swelling)；4 points (gum has ulcer
Or other symptoms).
3rd, plaque index (PLI)
It is divided into 4 grades according to bacterial plaque amount, 0 point (Yin Yuan areas are without bacterial plaque)；1 point (visual examination without bacterial plaque, but can be in free gum with probe
And proximity scrapes thin layer bacterial plaque)；2 points (in gingival pocket, dissociate gum area or the soft deposit adjacent to the visible moderate bulk amount of facing
Thing)；3 points (in gingival pocket or free gum area and neighbouring facing have a large amount of soft deposit things).
4th, test result
GI, SBI, PLI value take the average value of trial volunteer's situation in every group, and result of the test is shown in Table 2~4.
The test group of table 2 and the GI values of control group compare
| Test group | Before experiment | After 4 weeks | After 8 weeks |
| Test group | 1.71±0.45 | 1.24±0.45 | 0.55±0.50 |
| Control group I | 1.63±0.36 | 1.50±0.55 | 1.42±0.36 |
| Control group II | 1.69±0.49 | 1.50±0.46 | 1.40±0.59 |
| Control group III | 1.70±0.47 | 1.59±0.48 | 1.45±0.48 |
| Control group IV | 1.69±0.68 | 1.62±0.59 | 1.60±0.63 |
The test group of table 3 and the SBI values of control group compare
| Test group | Before experiment | After 4 weeks | After 8 weeks |
| Test group | 3.27±0.43 | 2.03±0.53 | 1.44±0.59 |
| Control group I | 3.45±0.63 | 3.03±0.50 | 2.85±0.45 |
| Control group II | 3.52±0.45 | 3.02±0.44 | 2.81±0.20 |
| Control group III | 3.42±0.54 | 2.75±0.58 | 2.56±0.60 |
| Control group IV | 3.39±0.58 | 3.26±0.45 | 2.96±0.61 |
The test group of table 4 and the PLI values of control group compare
| Test group | Before experiment | After 4 weeks | After 8 weeks |
| Test group | 2.37±0.55 | 1.64±0.45 | 1.02±0.60 |
| Control group I | 2.41±0.63 | 2.23±0.40 | 2.02±0.52 |
| Control group II | 2.46±0.50 | 2.06±0.55 | 1.60±0.55 |
| Control group III | 2.36±0.49 | 1.92±0.57 | 1.49±0.44 |
| Control group IV | 2.36±0.56 | 2.30±0.57 | 2.20±0.45 |
From table 2~4 as can be seen that compared with comparative example 1~4, the toothpaste containing oral care composition of the present invention
Effectively treatment gingivitis, more effectively treats bleeding gums, swelling and pain relieving, and test group is compared with control group, has conspicuousness
Difference (P ＜ 0.05).
Embodiment 14
Bacteriostatic test is carried out to mouthwash described in embodiment 6~8, comparative example 5, specific test method is as follows：
First, test strain：Staphylococcus aureus (ATCC 6538).
2nd, strain inoculum density is：With the good strain of normal saline dilution culture, 50cfu/g~200cfu/g bacterium solutions are made.
3rd, result count and evaluation
Result count：Result count is counted by bacterium colony technical method in GB/T 7918.2.
Evaluation method：The percentage declined using clump count is used as evaluation index.The calculation of the index is as follows：
In formula：A0The content of microorganisms of mouthwash during to be initially added microorganism；AnCounted for the detection time of different interval
Content of microorganisms.
4th, the standard of validity：
Microbiological indicator should be in attenuation state with time graph, and bacterium declines in strain sum in 30 minutes
99.9%, if can keep total number of bacteria in 12 hours, the fungistatic effect of judgement sample is good.Embodiment 6~8 and comparative example
The test result of 5 mouthwashes is shown in Table 5.
The test result of mouthwash described in the embodiment 6~8 of table 5 and comparative example 5
| Percentage (%) | Initially | 5 minutes | 30 minutes | 1 hour | 12 hours |
| Embodiment 6 | 100 | 100 | 99.9 | 99.9 | 99.6 |
| Embodiment 7 | 100 | 100 | 100 | 100 | 99.9 |
| Embodiment 8 | 100 | 100 | 100 | 100 | 100 |
| Comparative example 5 | 100 | 96.3 | 94.2 | 90.5 | 86.4 |
As can be seen from Table 5, embodiment 6~8 can keep the sum change of bacterium smaller within 12 hours, illustrate this hair
The fungistatic effect of the bright mouthwash is good.
Embodiment 15
Buccal cavity gel described in embodiment 9~11 and comparative example 6 is subjected to clinical test, specific method is as follows：
First, patient is grouped：100 patients of inclusive criteria will be met, random point 4 groups, every group 25, four groups of ages, property
Not, the course of disease and cardinal symptom are statistically analyzed, no significant difference (P>0.05), there is comparativity.
2nd, inclusive criteria：Clinical diagnosis is the patient of slight canker sore.
3rd, treatment method
Treatment group：2~3g of buccal cavity gel described in Example 9~11, after gargling, gel is applied to skin surface, often
Its medicine-feeding is twice.
Control group：Take 2~3g of buccal cavity gel described in comparative example 6, after gargling, gel is applied into skin surface, daily medicine-feeding
Twice.
4th, curative effect index
Criterion is used as with the minification for oozing out congested area of ulcer.Minification is considered as recovery from illness for 100%, reduces
Rate is that 80% to be considered as effect notable, and minification is 60% to be considered as effectively, and minification is 40% to be considered as that curative effect is weaker, and minification is less than
Or be considered as equal to 20% it is invalid.
5th, treatment results are shown in Table 6.
The treatment results of buccal cavity gel described in the embodiment 9~11 of table 6 and comparative example 6
As can be seen from Table 6, the therapeutic effect of 9~11 buccal cavity gel of embodiment is substantially better than mouth described in comparative example 6
Chamber gel, illustrate the problem of buccal cavity gel of the present invention can help to improve canker sore and promote repairing for canker sore
It is multiple.
Finally, it should be noted that the above embodiments are merely illustrative of the technical solutions of the present invention rather than the present invention is protected
The limitation of scope is protected, although being explained in detail with reference to preferred embodiment to the present invention, one of ordinary skill in the art should
Understand, technical scheme can be modified or equivalent substitution, without departing from the essence of technical solution of the present invention
And scope.
Claims (7)
1. a kind of oral care composition, it is characterised in that include Cordyceps militaris elite, O- cymene -5- alcohol and sylvite；The pupa
Lungfit is the mixture of Cordyceps militaris extract and fruiting bodies of cordyceps militaris.
2. oral care composition as claimed in claim 1, it is characterised in that the Cordyceps militaris elite and the O- cymenes-
The weight ratio of 5- alcohol is：0.5~50:0.1~1；The weight of the O- cymenes -5- alcohol and the thing of the Potassium In Potassium ion
The ratio between amount of matter is：(0.1~1) g：(0.3~1) mol.
3. oral care composition as claimed in claim 1, it is characterised in that the Cordyceps militaris elite and the O- cymenes-
The weight ratio of 5- alcohol is：1~30:0.5~0.8；The weight of the O- cymenes -5- alcohol and the thing of the Potassium In Potassium ion
The ratio between amount of matter is：(0.5~0.8) g：(0.3~0.53) mol.
4. oral care composition as claimed in claim 1, it is characterised in that the fruiting bodies of cordyceps militaris is in Cordyceps militaris elite
Weight percentage be 0.01~20%.
5. oral care composition as claimed in claim 1, it is characterised in that the fruiting bodies of cordyceps militaris is in Cordyceps militaris elite
Weight percentage be 8~15%.
6. oral care composition as claimed in claim 1, it is characterised in that the sylvite is potassium nitrate, potassium citrate, chlorination
At least one of potassium and potassium oxalate.
A kind of 7. application of oral care composition as any one of claim 1~6 in oral care product is prepared；
The oral care product is toothpaste, mouthwash or buccal cavity gel.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710635933.1A CN107485584B (en) | 2017-07-28 | 2017-07-28 | Oral care composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710635933.1A CN107485584B (en) | 2017-07-28 | 2017-07-28 | Oral care composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN107485584A true CN107485584A (en) | 2017-12-19 |
| CN107485584B CN107485584B (en) | 2020-08-25 |
Family
ID=60644941
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710635933.1A Expired - Fee Related CN107485584B (en) | 2017-07-28 | 2017-07-28 | Oral care composition |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107485584B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108836888A (en) * | 2018-04-25 | 2018-11-20 | 佛山科学技术学院 | A kind of tooth antiallergic composition |
| WO2020147953A1 (en) | 2019-01-17 | 2020-07-23 | Symrise Ag | An antimicrobial mixture |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101502482A (en) * | 2009-03-27 | 2009-08-12 | 玉溪健坤生物药业有限公司 | Toothpaste containing coenzyme Q10 and preparation method thereof |
| US20100098733A1 (en) * | 2008-10-16 | 2010-04-22 | Novan, Inc. | Nitric oxide releasing particles for oral care applications |
| US20110076240A1 (en) * | 2008-04-18 | 2011-03-31 | Day Donal F | Antifungal and Anti-Cariogenic Cellobio-Oligosaccharides Produced by Dextransucrase |
| US20130108561A1 (en) * | 2011-10-31 | 2013-05-02 | T.F.H. Publications, Inc. | Compositions for improving the oral health of animals, methods using the same, and pet treats incorporating the same |
| CN103766545A (en) * | 2014-01-02 | 2014-05-07 | 隋新 | Preparation method of cordyceps militaris extractive-rich cordyceps militaris tea |
| CN104666621A (en) * | 2015-02-03 | 2015-06-03 | 湖南炎帝生物工程有限公司 | Traditional Chinese medicine composition playing roles of stopping bleeding, diminishing inflammations and preventing bacteria and toothpaste containing same |
| CN105456041A (en) * | 2015-12-11 | 2016-04-06 | 广州薇美姿实业有限公司 | Toothpaste containing particles and transparent viscous substance |
| CN106491390A (en) * | 2016-12-13 | 2017-03-15 | 美晨集团股份有限公司 | A kind of persistently refrigerant antibacterial oral cavity cleaning and nursing liquid and preparation method thereof |
| CN106511112A (en) * | 2016-12-13 | 2017-03-22 | 美晨集团股份有限公司 | Toothpaste with lasting cooling and bacteriostatic effects and preparation method of toothpaste |
-
2017
- 2017-07-28 CN CN201710635933.1A patent/CN107485584B/en not_active Expired - Fee Related
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110076240A1 (en) * | 2008-04-18 | 2011-03-31 | Day Donal F | Antifungal and Anti-Cariogenic Cellobio-Oligosaccharides Produced by Dextransucrase |
| US20100098733A1 (en) * | 2008-10-16 | 2010-04-22 | Novan, Inc. | Nitric oxide releasing particles for oral care applications |
| CN101502482A (en) * | 2009-03-27 | 2009-08-12 | 玉溪健坤生物药业有限公司 | Toothpaste containing coenzyme Q10 and preparation method thereof |
| US20130108561A1 (en) * | 2011-10-31 | 2013-05-02 | T.F.H. Publications, Inc. | Compositions for improving the oral health of animals, methods using the same, and pet treats incorporating the same |
| CN103766545A (en) * | 2014-01-02 | 2014-05-07 | 隋新 | Preparation method of cordyceps militaris extractive-rich cordyceps militaris tea |
| CN104666621A (en) * | 2015-02-03 | 2015-06-03 | 湖南炎帝生物工程有限公司 | Traditional Chinese medicine composition playing roles of stopping bleeding, diminishing inflammations and preventing bacteria and toothpaste containing same |
| CN105456041A (en) * | 2015-12-11 | 2016-04-06 | 广州薇美姿实业有限公司 | Toothpaste containing particles and transparent viscous substance |
| CN106491390A (en) * | 2016-12-13 | 2017-03-15 | 美晨集团股份有限公司 | A kind of persistently refrigerant antibacterial oral cavity cleaning and nursing liquid and preparation method thereof |
| CN106511112A (en) * | 2016-12-13 | 2017-03-22 | 美晨集团股份有限公司 | Toothpaste with lasting cooling and bacteriostatic effects and preparation method of toothpaste |
Non-Patent Citations (2)
| Title |
|---|
| 史密斯 等: "《食品添加剂实用手册》", 30 November 2004, 中国农业出版社 * |
| 吴补领 等: "《老年口腔医学》", 30 November 2015, 西安交通大学出版社 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108836888A (en) * | 2018-04-25 | 2018-11-20 | 佛山科学技术学院 | A kind of tooth antiallergic composition |
| WO2020147953A1 (en) | 2019-01-17 | 2020-07-23 | Symrise Ag | An antimicrobial mixture |
Also Published As
| Publication number | Publication date |
|---|---|
| CN107485584B (en) | 2020-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103893026B (en) | It is a kind of to be used for oral cleaning and the mouthwash of health care | |
| CN107184476A (en) | A kind of antibacterial mouthwash and preparation method thereof | |
| CN107281013A (en) | One kind removes tooth stain and suppresses bacterial plaque toothpaste | |
| CN107595750B (en) | Active anti-inflammation toothpaste | |
| CN106821950A (en) | The oral care composition and its application of a kind of antibacterial and whitening | |
| CN102378627A (en) | Antibacterial composition comprising 4 -isopropyl-3-methylpheno and zinc ions | |
| CN107468553A (en) | A kind of anti-caries toothpaste | |
| CN107998036A (en) | A kind of toothpaste and its manufacture method for oral cavity synthtic price index | |
| TW200812637A (en) | Vegetable composition for cleaning oral cavity | |
| CN107441014A (en) | A kind of evening clothing toothpaste of American-cockroach-extract-containing and preparation method thereof | |
| CN109528601B (en) | Compound traditional Chinese medicine mouth wash and preparation method thereof | |
| CN102293725A (en) | Manufacture process for gargle used for oral cavity cleanness | |
| Akande et al. | Efficacy of different brands of mouth rinses on oral bacterial load count in healthy adults | |
| CN112263606A (en) | Traditional Chinese medicine gargle and preparation method thereof | |
| KR20150027352A (en) | Mouthwash Composition Using Natural Materials and the Manufacturing Method Thereof | |
| CN101829027B (en) | Multifunctional mouthwash | |
| CN107049828A (en) | A kind of anti-caries toothpaste and preparation method thereof | |
| Nigam et al. | Formulation and evaluation of herbal mouthwash against oral infections disease | |
| CN107485584A (en) | A kind of oral care composition | |
| CN110731931B (en) | Health toothpaste containing miracle fruit effective component | |
| CN102000333B (en) | Immunoglobulin (IgY) antibody oral spray for preventing decayed teeth | |
| Teke et al. | In vitro antimicrobial activity of some commercial toothpastes | |
| CN106420938B (en) | A kind of Chinese medicine composition and preparation method thereof for treating oral inflammation and pharyngitis | |
| CN106309740A (en) | Drug for cleaning oral cavities | |
| CN1173323A (en) | Composition for enhancing oral hygiene |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| TA01 | Transfer of patent application right | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20181224 Address after: 510000 Room 23, Jinzhu Second Street, Nansha District, Guangzhou City, Guangdong Province (Office only) Applicant after: Jiannan (China) Co.,Ltd. Address before: 510000 Block E 3601, Poly World Trade Building, 1022 Xingang East Road, Haizhu District, Guangzhou City, Guangdong Province Applicant before: EAGLESTAR (CHINA) CO.,LTD. |
|
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20200825 |